[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Tumor Marker Testing Market, 2019-2023: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

July 2019 | 185 pages | ID: T6E4674AF4EEN
Venture Planning Group

US$ 3,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 185 pages
CURRENT AND EMERGING TECHNOLOGIES

MONOCLONAL AND POLYCLONAL ANTIBODIES

IMMUNOASSAYS

a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  Immunofiltration
  Particle-Membrane Capture Immunoassay
  Enzyme Amplification
  d. Fluorescent Immunoassays
  e. Luminescence
  Chemiluminescence
  Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay

MOLECULAR DIAGNOSTICS

a. Technology Overview
b. Amplification Methods
  PCR
  DAP-PCR
  Immuno-PCR
  QC-PCR
  CAR
  DNA
  HPA
  LCR
  NASBA
  QBR
  SDA
  3 SR, and others

CHROMOSOME ANALYSIS

a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
Artificial Intelligence
Flow Cytometry
Two Dimensional Gel Electrophoresis (2-DGE)
Biosensors
Competing/Complementing Technologies
  a. CT
  b. MRI
  c. NMR
  d. PET
  e. Photonics Spectroscopy

COMPETITIVE PROFILES

Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila/Alere


More Publications